ETF PRO AIOctober 3, 2026
PBE Invesco Dynamic Biotechnology & Genome ETF
Fund tearsheet · data as of the latest session · October 3, 2026
ONE YEAR OF DAILY CLOSES
0.58%expense ratio
$424Mfund assets
+15.7%return, YTD
+32.0%return, 1 year
−$55Mnet flow, 1 month
+$114Mnet flow, 1 year
18.9%realized volatility, 1y
-11.8%worst drawdown, 1y
Top ten holdings
| 1 | NTRA NATERA | 6.23% |
| 2 | ILMN ILLUMINA | 6.17% |
| 3 | BIIB BIOGEN | 5.19% |
| 4 | GILD GILEAD SCIENCES | 5.08% |
| 5 | RPRX ROYALTY PHARMA | 4.77% |
| 6 | VRTX VERTEX PHARMACEUTICALS | 4.80% |
| 7 | AMGN AMGEN | 4.84% |
| 8 | REGN REGENERON PHARMACEUTICALS | 4.62% |
| 9 | MRNA MODERNA | 3.36% |
| 10 | NVAX NOVAVAX | 3.17% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS